Structure Therapeutics

IPO

Medicine is our platform. Accessibility is our cure.

Public · South San Francisco, United States · Founded 2021 · $100.0M raised

Employees
51–200
Founded
2021
Business Model
B2B
Total Funding
$100.0M
Last Round
$100.0M Series BOct 2021
Rounds
1
Type
Public

About

Structure Therapeutics is a clinical-stage biopharmaceutical company leveraging structure-based drug design to develop oral small molecule therapeutics for chronic diseases including obesity. The company's platform applies proprietary GPCR structural knowledge and computational chemistry to build a broad pipeline of non-peptide medicines that are more scalable and accessible than biologics or injectable peptide therapies.

Summary

Structure Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2021. It has raised $100.0M in total across 1 round, most recently a $100.0M Series B round in Oct 2021. Investors include Eight Roads Ventures, F-Prime Capital and Qiming VP.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOApr 2026
$650.0M

Sign up to see all 2 rounds

Series B through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Structure Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/structure-therapeutics"><img src="https://indexed.vc/api/badge/company/structure-therapeutics" alt="Structure Therapeutics on Indexed.vc" width="260" height="76" /></a>